Hepatic Steatosis, Body Mass Index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases

S. Pathak (1) , J.M.F. Tang (2) , M. Terlizzo (3) , G.J. Poston (1)

1 Department of General Surgery
2 University of Liverpool
3 Department of Pathology

Hepatic Steatosis (HS) is as an independent risk factor for morbidity and mortality post-hepatectomy. Recent studies report significant correlation between chemotherapy (now frequently employed pre-hepatectomy for Colorectal liver metastases (CRLM)), HS and steatohepatitis. Furthermore, raised body mass index (BMI) predisposes to HS. However, no previous study has analysed the effect of HS on long-term survival.

Mots clés: hepatic steatosis; Body Mass Index; Neo-adjuvant chemotherapy; post operative outcome

S. Pathak, J.M.F. Tang, M. Terlizzo, G.J. Poston. Hepatic Steatosis, Body Mass Index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases. EJSO - European Journal of Surgical Oncology, 2010, 36 (1), pp.52. ⟨10.1016/j.ejso.2009.09.004⟩. ⟨hal-00556322⟩